{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-177288","form_type":"8-K","ticker":"APGE","cik":"0001974640","company_name":"Apogee Therapeutics, Inc.","filed_at":"2026-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.340282+00:00","generated_at":"2026-05-15T04:16:15.988330+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Two directors resign from Apogee board; board shrinks from 9 to 7","bullets":["Andrew Gottesdiener, M.D. and Peter Harwin notified Board of resignations effective May 11, 2026.","Resignations are not due to any disagreement with Company's operations, policies or practices.","Board size will be reduced from nine to seven directors effective May 11, 2026.","No replacements announced; CEO Michael Henderson remains in role."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-177288","json":"https://secwatch.observer/filing/0001193125-26-177288.json","markdown":"https://secwatch.observer/filing/0001193125-26-177288.md","text":"https://secwatch.observer/filing/0001193125-26-177288.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177288/0001193125-26-177288-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177288/apge-20260421.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:16:15.988330+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}